LARA Releases Advisory Bulletin Clarifying the Use of CBD and Hemp Products
Media Contact: LARA Communications 517-373-9280
May 10, 2018 – The Dept. of Licensing and Regulatory Affairs (LARA) and the Bureau of Medical Marihuana Regulation (BMMR) released an advisory bulletin today clarifying how cannabidiol (“CBD”) and industrial hemp (“hemp”) are regulated in the state of Michigan.
Based on the statutory definitions related to “marihuana” found in the Michigan Public Health Code, the Michigan Medical Marihuana Act, and the Medical Marihuana Facilities Licensing Act, any extracts of marihuana or extracts of the marihuana plant will continue to be treated as marihuana. The possession, purchase, or sale of marihuana or any marihuana product – including CBD – must be done in compliance with the MMMA and MMFLA.
Marihuana does not include industrial hemp grown or cultivated (or both) for research purposes under the industrial hemp research act. The Industrial Hemp Research Act limits industrial hemp to cultivation or research and does not authorize its sale or transfer. Any possession or transfer of industrial hemp – or any product claimed to be “hemp”-related – must be done in compliance with Michigan’s Industrial Hemp Research Act.
The full text of the advisory bulletin can be found here.